期刊文献+

重组人肝再生增强因子的纯化及生物学活性分析 被引量:1

Purification and Biological Activity of Recombinant Human Augmenter of Liver Regeneration
下载PDF
导出
摘要 目的 对在大肠杆菌中表达的重组人肝再生增强因子(rhALR)进行分离纯化及生物学活性分析.方法 以大肠杆菌DH5α发酵表达重组人肝再生增强因子,经包涵体洗涤、变性、目的蛋白复性,以离子交换、分子筛等技术纯化,并进行一系列检定.结果 目的 蛋白以包涵体形式存在,经变性、复性及柱层析纯化,纯度大于98%,SDS-PAGE测定相对分子质量为30 000,MOLDI-TOF-MS测定其相对分子质量为30 780.522,N-末端15个氨基酸与理论序列一致.Western blot证实rhALR正确表达,等电点5.85~6.85,氨基酸含量与理论值基本符合.动物实验证实rhALR具有明显的促进CCl4毒性肝损伤小鼠肝细胞修复活性.结论 经柱层析纯化的rhALR具有促进小鼠CCl4肝损伤肝细胞修复的活性. Objective To separate, purify and study the biological activity of recombinant human augutenter of liver regeneration(rhALR) expressed in E. coli. Methods Incubate the recombinant E. coli strain pBV220-rhALR/DHSα by fermentation and induce the expression of rhALR. Treat the expressed product in a form of inclusion body by washing, de-naturalization and re-naturalization,then purify by ion exchange and molecular sieve chromatography and perform control tests. Results The expressed product reached a purity of more than 98% after purification, and its relative molecular weight was proved as 30 000 by SDS-PAGE and 30 780. 522 by MOLDI-TOF-MS. The sequence of 15 amino acids at N-termlnus of the expressed product was identical to that in theory. Western blot proved that rhALR with a pI of 5.85-6. 85 was correctly expressed, and its amino acid content was basically consistent with the theoretical value. Animal test proved that rhALR promoted the restoration of liver cells of CCl4 -intosicated mice significantly. Conclusion The rhALR purified by column chromatography showed significant activity of rhALR in promoting the restoration of liver cells of CCl4-intosicated mice.
出处 《中国生物制品学杂志》 CAS CSCD 2006年第5期505-508,共4页 Chinese Journal of Biologicals
关键词 重组人肝再生增强因子 层析 生物活性 Recombinant human augmenter of liver regeneration (rhALR) Chromatography Biological activity
  • 相关文献

参考文献5

二级参考文献21

  • 1刘顺爱,毕无邪,杨贵贞.用一种新的免疫方法制备抗NPY单克隆抗体[J].中国免疫学杂志,1995,11(2):92-94. 被引量:6
  • 2[1]Starzel TE,Scanlan WA,Thornton,et al.Effect of insulin on glucose metabolism in the dog after portacaval transposition.Am J Physiol,1965,209:221 - 226.
  • 3[2]Starzel TE,Kaupp HA Jr,Brock DR,et al.Reconstructive problems in canine liver homotransplantation with special reference to the postoperative role of hepatic venous flow.Surg Gynecol Obstet,1960,111:733 - 743.
  • 4[3]Francavilla A,Starzel TE,Porter K,et al.Screening for candidate hepatic growth factor by selective portal infusion after canine Eck fistula.Hepatology,1991,14:665 - 670.
  • 5[4]Francavilla A,Hagiya M,Porter KA,et al.Augmenter of liver regeneration(ALR) :its place in the universe of hepatic growth factors.Hepatology,1994,20:747 - 757.
  • 6[5]Starzel TE,Porter KA,Putnam CM.Imtraportal insulin protects from the liver injury of portcaval shunt in dogs.Lancet,1975,2:1241 - 1246.
  • 7[6]Francavilla A,Polimeno L,Barone M,et al.Hepatic regeneration and growth factors.J Surg Oncol,1993,3(Suppl):1 - 7.
  • 8[7]Fausto N,Laird AD,Webbet EM,et al.Role of growth factors and cytokines in hepatic regeneration.FASEB J,1995; 9:1527 -1536.
  • 9[8]He F,Wu C,Tu Q,et al.Human hepatic stimulator substance:A product of gene expression of human fetal liver tissue.Hepatology,1993; 17:225 - 229.
  • 10[9]Hagiya M,Francavilla A,Polimeno L,et al.Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene:Expression of biologically active recombinant ALR and demonstration of tissue distribution.Proc Natl Acad Sci USA,1994,91:8142- 8146.

共引文献32

同被引文献24

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部